まとめ
アトロピンはダイアストロリック時間とダイアストロルの割合を大幅に短縮し,冠動脈疾患の患者に潜在的に心筋動脈不全のリスクを高めます.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
背景:
- 動脈の静脈回路は,冠動脈の perfusion に非常に重要です.
- アトロピンの心血管効果を理解することは,患者の安全のために重要です.
研究 の 目的:
- 健康なボランティアの心拍数とダイアストリック時間に対する静脈内アトロピンの影響を調査する.
- アトロピンとイソプロテレノールがダイアストリック機能に及ぼす効果を比較する.
主な方法:
- 10人の健康なボランティアは,静脈注入アトロピン (0.01-0.04 mg/kg) のエスカレートする用量を投与された.
- 心拍数,透析時間,および透析率のパーセントを測定した.
- 効果は,イソプロテレノールと比較された.
主要な成果:
- アトロピンは心拍数を増やし,ダイアストリック時間およびダイアストールの割合 (p < 0.001) を大幅に減少させた.
- イソプロテレノールは心拍数を増加させましたが,静脈回転時間および静脈回転率のパーセントにはそれほど顕著な効果はありませんでした.
- アトロピンの臨床的に関連する用量は,ダイアストリック充填期間を著しく短縮しました.
結論:
- アトロピンの投与は,ダイアストリック時間を大幅に短縮し,百パーセントのダイアストルを減少させることができます.
- このダイアストリック時間の短縮は,冠動脈 perfusion を損なう可能性があります.
- 冠動脈疾患の患者におけるアトロピンの使用は,潜在的に心筋不全を悪化させる可能性があります.
関連する概念動画
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...


